PharmGKB contains no dosing guidelines for this drug class. To report known genotype-based dosing guidelines, or if you are interested in developing guidelines, click here.
PharmGKB contains no drug labels with pharmacogenomic information for this drug class. To report a drug label with PGx, click here.
PharmGKB contains no clinical annotations for this drug class. To report clinical variants, click here.
PharmGKB contains no genetic testing information for this drug class. To report genetic tests, click here.
Overview
Generic Names
Trade Names
Brand Mixture Names
PharmGKB Accession Id:
PA452642
ATC Therapeutic Category
- L01CB:Podophyllotoxin derivatives
Drugs And Small Molecules
The following have been classified under this therapeutic category:
Publications related to podophyllotoxin derivatives: 1
|
Relationships between genetic polymorphisms and anticancer drug cytotoxicity vis-à-vis the NCI-60 panel. Pharmacogenomics. 2006. Le Morvan Valérie, et al. [Article:16981845@PubMed] |